Support program to improve quality of life for Chinese cancer patients and survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program tests combinations of cancer education sessions, meaning-centered counseling, peer support meetings, and enhanced standard care delivered largely via telehealth. Eligible participants are adults of Chinese descent who speak Mandarin, were diagnosed with cancer within the past five years, and report moderately low health-related quality of life (FACT-G <70). Sessions will be audio-recorded for fidelity, and participants with active suicidal risk are excluded and referred for higher-level care. The research team will track practicality (feasibility, engagement) and changes in quality of life over the intervention period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years
* Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)

Self-Report Criteria:

* Of Chinese descent
* Speaks Mandarin "well" or "very well"
* Moderately low HRQOL (\<70 FACT-G score)4, 48
* Resides in New York or New Jersey
* Agrees to participate via telehealth (video or phone)
* Agrees to be audio-recorded

Exclusion Criteria:

Self-Report Criteria:

* Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of \> 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
* Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
* Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score \< 12)
* Per consenting professional determination, unable to understand the informed consent procedure
* Participation in study #14-076: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese immigrant cancer patients)
* Currently receiving/have received psychotherapy/counseling/peer support within the last 6 months (patients being treated solely with psychotropic medications will not be excluded if they are not receiving psychotherapy/counseling/peer support)

Where it's running

• Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
  Basking Ridge, New Jersey, United States Recruiting
• Memorial Sloan Kettering Monmouth (All Protocol Activities)
  Middletown, New Jersey, United States Recruiting
• Memorial Sloan Kettering Bergen (All Protocol Activities)
  Montvale, New Jersey, United States Recruiting
• Memorial Sloan Kettering Cancer Center Suffolk- Commack (All Protocol Activities)
  Commack, New York, United States Recruiting
• Memorial Sloan Kettering Westchester (All Protocol Activities)
  Harrison, New York, United States Recruiting
• Memorial Sloan Kettering Cancer Center (All Protocol Activities)
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Florence Lui, PhD — Memorial Sloan Kettering Cancer Center
• Study coordinator: Florence Lui, PhD
• Email: luif@mskcc.org
• Phone: 646-888-8375

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive training with real-time brain feedback for childhood medulloblastoma survivors

  This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07830134

• Hematologic cancer survivors after stem cell transplant try a personalized care plan

  This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07579065

• On-Trac: Online training to manage anxiety after cancer

  This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07305740

• Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction

  This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.

  Recruiting University of Virginia · Charlottesville, Virginia · NCT07264036

• LiveWell: a tailored DBT skills program for people living with metastatic lung cancer

  This pilot randomized trial tests a telehealth DBT skills program called LiveWell for adults with metastatic non-small cell lung cancer and distress to see if it reduces distress and improves well-being compared to usual care.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07177846

• Quality of life and medical care for long-term sarcoma survivors in Germany (PROSa+)

  This project will ask adults in Germany who were diagnosed with sarcoma at least five years ago to complete questionnaires and some interviews to see how cancer and its treatments affect their quality of life and medical care.

  Recruiting at 4 sites Technische Universität Dresden · Dresden, Saxony and 4 other locations · NCT07148193

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.